Amyloidosis Therapeutics Pipeline Market H1 2015 Research Report Available at RnRMarketResearch.com
The report "Amyloidosis – Pipeline Review, H1 2015 provides comprehensive information on the therapeutic development for Amyloidosis. Amyloidosis is a rare but serious condition in which an abnormal protein builds up in tissues and organs. Two thirds of patients with amyloidosis are male and less than 5% of patients are under 40 years of age. The cause of primary amyloidosis is unknown and it can lead to conditions that include Carpal tunnel syndrome, Heart muscle damage, Kidney failure, Intestinal malabsorption,...
View full press release